Chancity

Fierce Pharma Week 2026 (dates TBA)

Fierce Pharma Week is an in-person event for leaders across Pharma Marketing, Medical Affairs, Commercialization, and PR & Communications.

Format
Four days, in person
Attendance
3,000+ attendees
Decision-makers
1,700+ senior decision-makers
Program
14 tracks and 200+ sessions

TL;DR

  • Fierce Pharma Week 2026 is framed as a four-day, in-person event.
  • The program spans 14 specialized content tracks and more than 200 sessions.
  • The event draws 3,000+ attendees, including 1,700+ senior decision-makers.
  • The organizer lists 400+ industry speakers.

Source: fiercepharmaweek.com/fiercepharmaweekcom/full-agenda-fierce-pharma-week

About

Fierce Pharma Week brings together leaders across Pharma Marketing, Medical Affairs, Commercialization, and PR & Communications. Its released in-person agenda lists 200+ sessions across those core functions. The 2026 program adds Sales Enablement, Data, Analytics and Commercial Intelligence, and Market Access tracks.

Who you'll find in the room

Senior decision-makers

The audience includes 1,700+ senior decision-makers.

Pharma functional leaders

Attendee functions include Pharma Marketing, Medical Affairs, Commercialization, and PR & Communications.

Featured speakers

6 listed

Robert (Bob) Allen

Head, Omnichannel Strategy & Digital Transformation, Global Public Affairs · Gilead Sciences

David Bell

Chief Commercial Officer · Cosette Pharma

Petra Kaufmann, M.D.

Chief Medical Officer · Ovid Therapeutics

Div Khetia, PharmD

Vice President, Medical Affairs Channel Excellence and Medical Digital Health Solutions · Pfizer

Justin Holko

Senior Vice President & Head, Global Oncology/Hematology Commercial Business Unit · Regeneron

Sriram Jambunathan

Head of Marketing and Commercial Strategy, U.S. Vaccines · Sanofi

Questions people ask

4 answered

Fierce Pharma Week draws 3,000+ attendees.

Attendees include leaders across Pharma Marketing, Medical Affairs, Commercialization, and PR & Communications. The audience includes 1,700+ senior decision-makers.

It is most worthwhile for commercial, marketing, medical affairs and communications professionals in pharma, since the 200+ sessions and 14 tracks are built around those functions and the speakers include executives from Pfizer, Regeneron, Sanofi and Gilead Sciences. The 1,700+ senior decision-makers among 3,000+ attendees also make it a sensible place for vendors to meet buyers, and the new Market Access and Data, Analytics and Commercial Intelligence tracks widen the draw. Professionals outside those commercial and medical functions, or anyone wanting a small and intimate room, would get less from a show of this scale.

Pharma commercial and marketing professionals usually wear business casual to business professional at large conferences, with comfortable shoes for moving between sessions and the exhibit area.

Related events

Find more events with this kind of reach.

We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.

Also listed in